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found that PC12 (pheochromocytoma) cells expressed SIRT1 in the cytoplasm. Nerve growth factor
(NGF)-induced neurite outgrowth of these cells was promoted by activators of SIRT1, while inhibi-
tors of SIRT1 or SIRT1-siRNA signiﬁcantly inhibited it. The overexpression of a mutant SIRT1 that
localised to the cytoplasm but not the nucleus enhanced the NGF-dependent neurite outgrowth,
and a cytoplasmic dominant-negative SIRT1 suppressed it. Thus, cytoplasmic SIRT1 increases the
NGF-induced neurite outgrowth of PC12 cells.
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SIRT1, an NAD+-dependent class III histone deacetylase [1],
deacetylates various nuclear proteins and participates in cell dif-
ferentiation, cell survival, tumorigenesis, and cell metabolism
[2,3]. SIRT1 is highly expressed in the foetal and adult brain [4,5].
It inhibits some neurological toxic insults in animal models of Alz-
heimer’s disease and amyotrophic lateral sclerosis [6]. Mutant,
Wallerian degeneration slow, mice have high NAD biosynthetic
activity, and the NAD-induced increase in SIRT1 activity may help
protect the axons [7]. In the postnatal period, SIRT1 binds to the
transcription factor Hes1 and promotes gliogenesis [8]. In addition,
we have shown that SIRT1 participates in embryonic neuronal dif-
ferentiation [9].
SIRT1 is a nucleocytoplasmic shuttling protein [10]. It is pre-
dominantly expressed in the cytoplasm of normal cardiomyocytes,
and translocates into the nucleus to protect cells from oxidative
stress during chronic heart failure [11]. Thus, in the heart, cytoplas-
mic SIRT1 may serve as a reservoir for nuclear SIRT1. On the other
hand, in neural precursor cells isolated from the embryonic brain,
SIRT1 is transiently localised to the nucleus in response to differen-chemical Societies. Published by E
armacology, Sapporo Medical
an. Fax: +81 11 612 5860.tiation stimuli and then re-translocates to the cytoplasm [9]. SIRT1
is also predominantly expressed in the cytoplasm of some NeuN+
neurons in the gray matter [9], but the cytoplasmic function of
SIRT1 in neurons, if any, is unknown.
PC12 cells, derived from a rat pheochromocytoma, are a well-
established model for studying neurite outgrowth. PC12 cells trea-
ted with nerve growth factor (NGF) cease proliferation, exhibit so-
matic hypertrophy, extend neurites, and differentiate [12].
In this study, we used PC12 cells to examine the function of
cytoplasmic SIRT1.
2. Materials and methods
2.1. Plasmids and siRNAs
Constructs for nucleus-directed (SIRT1-EGFP), cytoplasm-direc-
ted (mtNLS-EGFP), or nucleus-directed dominant-negative
(H355Y-EGFP) SIRT1-fused EGFP were described previously [10].
Cytoplasm-directed dominant-negative SIRT1-fused EGFP
(mtNLS-H355Y-EGFP) was constructed by inserting the BglII–EcoRV
fragment from mtNLS-EGFP into H355Y-EGFP digested with BglII
and EcoRV. The construct was conﬁrmed by DNA sequencing. Three
kinds of SIRT1-siRNAs (B-Bridge) were used [11]. The sense and
antisense SIRT1-siRNAs were as follows: No. 1: 50-GAACAAA-
GUUGACGAUUUAtt-30 (sense)/50-UAAAUCGUCAACUUUGUUCtt-30lsevier B.V. All rights reserved.
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Fig. 1. SIRT1 is predominantly expressed in the cytoplasm of PC12 cells. (A) SIRT1
immunostaining of undifferentiated and differentiated PC12 cells. For differentia-
tion, PC12 cells were cultured in differentiation medium containing NGF for 3 days.
SIRT1 was expressed in the cytoplasm and neurites. Bar, 10 lm. (B) Western blot
analysis of SIRT1. Cytoplasmic (Cyto) and nuclear (Nuc) fractions were prepared
from undifferentiated and differentiated PC12 cells. GAPDH and Lamin were
cytoplasmic and nuclear markers, respectively.
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Fig. 2. Modulators of SIRT1 activity affect the NGF-induced neurite outgrowth. (A and B
20 lM) or NAD (20 or 50 lM) for 1 h, and then subjected to differentiation by NGF in the
inhibitor of SIRT1, either nicotinamide (NA) (10 or 20 mM) or splitomicin (SP) (5 or 10 l
inhibitor for 3 days. Neuron J was used to quantify the longest neurite length (A and C) a
way ANOVA. *P < 0.05 versus control cells treated with DMSO.
2822 T. Sugino et al. / FEBS Letters 584 (2010) 2821–2826(antisense), No. 2: 50-GCAGAAACAGUGAGAAAAUtt-30 (sense)/50-AU-
UUUCUCACUGUUUCUGCtt-30 (antisense) and No. 3: 50-GCUCAGA-
GUUUGAGCAUAUtt-30 (sense)/50-AUAUGCUCAAACUCUGAGCtt-30
(antisense). Control siRNAs (B-Bridge) were a cocktail of the follow-
ing three siRNAs: 50-AUCCGCGCGAUAGUACGUAtt-30 (sense)/50-UA-
CGUACUAUCGCGCGGAUtt-30, 50-UUACGCGUAGCGUAAUACGtt-30
(sense)/50-CGUAUUACGCUACGCGUAAtt-30 (antisense) and 50-UAU-
UCGCGCGUAUAGCGGUtt-30 (sense)/50-CGUAUUACGCUACGCGUA-
Att-30 (antisense). Plasmids or siRNAs were electroporated into
PC12 cells using a Nucleofector kit (Amaxa). To identify the cells
containing siRNAs, pmaxGFP (Amaxa) was co-electroporated with
the siRNAs.
2.2. Cell culture
PC12 cells were grown at 37 C in 5% CO2 in Dulbecco’s modiﬁed
Eagle’s medium (DMEM; Sigma) containing 10% heat-inactivated
horse serum and 5% foetal bovine serum. Cells were plated at 50–
60% conﬂuence. To induce neurite outgrowth, the PC12 cells were
plated on poly-L-ornithine-coated coverslips, and the medium was
changed to a differentiation medium (DMEM plus 2% horse serum
and 1% foetal bovine serum) with 50 ng/ml NGF (Alomone Labs).
Splitomicinwas fromBIOMOL and other chemicalswere fromWako.
2.3. Immunocytochemistry
Immunostaining was carried out as described previously [10].
Anti-SIRT1 (1:500; [4]) and Alexa Fluor 594-conjugated goatTo
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) PC12 cells were treated with an activator of SIRT1, either resveratrol (RSV) (10 or
presence of the same activator for 3 days. (C and D) PC12 cells were treated with an
M) for 1 h, and then subjected to differentiation by NGF in the presence of the same
nd the total neurite length (B and D) for each cell. Differences were tested by a one-
T. Sugino et al. / FEBS Letters 584 (2010) 2821–2826 2823anti-rabbit antibodies (Molecular Probes) were used. Nuclei were
stained with 1 lM Hoechst 33342 (Wako). For cell membrane
staining, the cells were incubated with 2 lM cell tracker (Molecu-
lar Probes) for 5 min at 37 C and then for 15 min at 4 C before
mounting. The samples were examined by confocal microscopy
(Radiance 2100, Bio-Rad). Because confocal images cannot depict
structures that extend out of the plane of focus, we merged two
sections from different planes for each cell, to show the neu-
rites. The length of neurites on a cell was measured with Neuron
J (version 1.4.1), a program for neurite tracing and quantiﬁcation
developed by E. Meijering.
2.4. Immunoblotting
Immunoblotting was performed as described previously [9].
The Nuclear/Cytosol Fractionation kit (BioVision Research Prod-
ucts) was used to separate cellular fractions. Anti-GAPDH (Chem-
icon) and anti-Lamin A/C (Cell Signalling Technology) antibodies
were used as cytoplasmic and nuclear markers, respectively. To
strip bound antibodies, membrane ﬁlters were treated with Re-
Blot Plus (Chemicon).
2.5. Statistical analysis
More than 60 cells were examined in each experiment. Three
independent experiments were carried out under each experimen-A
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Fig. 3. SIRT1-siRNA represses NGF-induced neurite outgrowth. (A) Control siRNAs or each
then the cells were incubated in differentiation medium with NGF for 2 days. Representa
#2 SIRT1-siRNA suppressed SIRT1 expression. The longest neurite length (B) and total ne
ANOVA. *P < 0.05 versus cells expressing control siRNAs.tal condition. The results are presented as means ± S.E.M. Differ-
ences were tested by a one-way ANOVA. A P-value of less than
0.05 was considered signiﬁcant.
3. Results
3.1. Predominant expression of SIRT1 in the cytoplasm of PC12 cells
We found that SIRT1 was predominantly expressed in the cyto-
plasm of undifferentiated PC12 cells (Fig. 1A). The treatment of
PC12 cells with differentiation medium containing NGF-induced
their differentiation and promoted neurite outgrowth. SIRT1 was
still present in the cytoplasm and neurites of the PC12 cells 3 days
after differentiation (Fig. 1A). Western blot analysis also showed
that SIRT1 was predominantly detected in the cytoplasmic frac-
tions from undifferentiated and differentiated cells (Fig. 1B).
3.2. Effects of SIRT1 modulators on NGF-induced neurite outgrowth
We next explored whether the neurite outgrowth of PC12 cells
was affected by the SIRT1 activity. PC12 cells were treated with
activators or inhibitors of SIRT1 1 h before being switched to differ-
entiation medium, and they were then cultured under differentia-
tion conditions with the SIRT1 modulators for 3 days. Most of the
PC12 cells had several neurites after differentiation (see Fig. 4A).*
To
ta
l n
eu
rit
e 
le
ng
th
 (µ
m
) 
SIRT1-siRNA
0
20
40
60
80
100
120
SIRT1-siRNA
C
*
*
2 3
1 2 3
*
of SIRT1-siRNAs was electroporated into PC12 cells 24 h before differentiation, and
tive immunoblots of SIRT1 and GAPDH are shown. #1 and #3 SIRT1-siRNAs but not
urite length (C) were quantiﬁed by Neuron J. Differences were tested by a one-way
2824 T. Sugino et al. / FEBS Letters 584 (2010) 2821–2826We evaluated the length of the longest neurite and the total neu-
rite length for each cell. Resveratrol is a potent activator of SIRT1
[13]. The length of the longest neurite and the total neurite length
were signiﬁcantly longer for the cells treated with resveratrol than
control cells (Fig. 2A and B). The administration of NAD, a SIRT1
cofactor, also increased the neurite outgrowth under differentia-
tion conditions (Fig. 2A and B). In contrast, nicotinamide and spli-
tomicin, inhibitors of SIRT1, signiﬁcantly impaired the NGF-
induced neurite outgrowth (Fig. 2C and D). None of these positive
or negative modulators affected the number of neurites per cell
(data not shown).
3.3. Inhibition of NGF-induced neurite outgrowth by SIRT1-siRNA
The sirtuin family contains seven members, SIRT1-7. SIRT1
modulators affect not only SIRT1 but also other sirtuins. To evalu-
ate the function of SIRT1 speciﬁcally, three SIRT1-siRNAs or control
siRNAs along with GFP were introduced into PC12 cells one day be-
fore differentiation, and the neurite outgrowth was examined after
2 days under differentiation conditions (Fig. 3A). The protein level
of SIRT1 was signiﬁcantly decreased by the #1 and #3 SIRT1-siR-
NAs but not by the #2 SIRT1-siRNA (Fig. 3A). The NGF-induced
neurite outgrowth of the cells electroporated with the #1 or #3
SIRT1-siRNA signiﬁcantly decreased compared with that of cells
expressing control siRNAs (Fig. 3B and C). The neurite outgrowthEGFP
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Fig. 4. Cytoplasmic SIRT1 promotes NGF-induced neurite outgrowth. (A) EGFP, mtNLS-
SIRT1) was expressed in PC12 cells 24 h before differentiation, and then the cells were di
The focus was adjusted to identify neurites. Insets are confocal images with nuclear staini
were quantiﬁed by Neuron J. Differences were tested by a one-way ANOVA. *P < 0.05 vewas not affected by the #2 SIRT1-siRNA, that failed to decrease
SIRT1 expression.
3.4. Modulation of NGF-induced neurite outgrowth by cytoplasmic
SIRT1
The differentiated PC12 cells expressed SIRT1 in the cytoplasm
and neurites (Fig. 1A). We next explored whether the overexpres-
sion of cytoplasmic SIRT1 would promote the NGF-induced neurite
outgrowth of PC12 cells. mtNLS-EGFP (cytoplasmic SIRT1), which
has mutations in two of SIRT1’s nuclear localisation signals [10],
was expressed in the cytoplasm of PC12 cells (Fig. 4A middle panel,
inset). The length of the longest neurite on the cells overexpressing
cytoplasmic SIRT1 was signiﬁcantly longer than that of control
cells overexpressing EGFP alone (Fig. 4A and B).
When mtNLS-H355Y-EGFP (cytoplasmic dominant-negative
SIRT1) was expressed in PC12 cells, it was detected in the cyto-
plasm as expected (Fig. 4A right panel, inset). The cytoplasmic
dominant-negative SIRT1 failed to increase the NGF-induced neu-
rite extension under differentiation conditions (Fig. 4A and B),
demonstrating that the promotion of neurite outgrowth by cyto-
plasmic SIRT1 required SIRT1’s enzymatic activity. Furthermore,
the total length of the neurites on cells expressing the cytoplasmic
dominant-negative SIRT1 was signiﬁcantly shorter than that on
control cells under differentiation conditions (Fig. 4C).S-EGFP 
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EGFP (nuclear dominant-negative SIRT1; DN-SIRT1), which were
exclusively localised to the nucleus of PC12 cells (Fig. 5A). The
overexpression of neither nuclear SIRT1 nor DN-SIRT1 promoted
the NGF-induced neurite outgrowth (Fig. 5B and C); rather, these
molecules reduced the total neurite length.
4. Discussion
In this study, we demonstrated that SIRT1 was expressed in the
cytoplasm of PC12 cells and modulated their NGF-dependent neu-
rite outgrowth. We further showed that cytoplasmic SIRT1 but not
nuclear SIRT1 promoted the neurite outgrowth. Neural precursor
cells express SIRT1 in the cytoplasm [9]. The in utero electropora-
tion of SIRT1-siRNA into neural precursor cells of the E14 brain
abolishes the normal bipolar formation of the cells examined at
E17; instead, these cells are round and have few or short processesEGFP
SIRT1          
-EGFP
H355Y-
EGFP   
(DN-SIRT1)
EGFPA
B
Lo
ng
es
t n
eu
rit
e 
le
ng
th
 (µ
m
) 
Control SIRT1 DN-
SIRT1
0
10
20
30
40 NS
NS
Fig. 5. Nuclear SIRT1 fails to promote NGF-induced neurite outgrowth. (A) EGFP, SIR
expressed in PC12 cells, and then the cells were differentiated with NGF for 2 days. Repr
shown. Bars: 10 lm. The longest neurite length (B) and total neurite length (C) were qua
difference. *P < 0.05 versus control cells expressing EGFP.[9]. Taken together, these data indicate that SIRT1 may participate
in the formation of axons or dendrites by neurons during brain
development. A neurite differentiates into an axon or a dendrite
in the brain. At present, it is not known if SIRT1 affects axonal or
dendritic formation. To determine whether SIRT1 affects axon-
dendrite speciﬁcation, studies using primary cultures of hippocam-
pal pyramidal neurons or cortical neurons should be performed.
SIRT1 deacetylates nuclear proteins such as histones, transcrip-
tion factors, and cofactors. Because cytoplasmic SIRT1 and cyto-
plasmic dominant-negative SIRT1 affected neurite outgrowth
(Fig. 4), SIRT1 may directly deacetylate and modulate a cytoplas-
mic protein that participates in the formation and extension of
neurites. Accordingly, SIRT1 is expressed in neurites (Fig. 1A). A re-
cent study using GST-fusion SIRT1 and mass spectrometry showed
that SIRT1 interacts with several cytoplasmic and membrane-
bound proteins, including molecules of the Ras superfamily signal-
ling pathway [14]. Because the Ras GTPase family is involved inHoechst Cell tracker
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2826 T. Sugino et al. / FEBS Letters 584 (2010) 2821–2826neurite outgrowth [15], SIRT1 may affect small GTPase cascades.
The inhibition of HDAC6, a class II cytoplasmic histone deacetylase,
has been shown to affect neurite growth [16]. Because HDAC6 is
also predominantly expressed in the cytoplasm, a cytoplasmic pro-
tein that affects neurite outgrowth may be modulated by acetyla-
tion and deacetylation. SIRT2, another member of the sirtuin
family, is a tubulin deacetylase. SIRT2 inhibits the neurite out-
growth of postmitotic hippocampal neurons [17]. Our preliminary
study failed to show the deacetylation of tubulin by SIRT1 (data not
shown). Thus, SIRT1 and SIRT2 may play different roles in the cyto-
plasm. Nuclear SIRT1 and dominant-negative SIRT1 inhibited the
outgrowth of the total neurites per cell (Fig. 5C). At present, the
mechanism by which nuclear overexpression of SIRT1 inhibits neu-
rite outgrowth is unknown.
In summary, in PC12 cells, cytoplasmic but not nuclear SIRT1
promotes NGF-induced neurite outgrowth in a manner that de-
pends on SIRT1’s deacetylation activity. The modulation of SIRT1
localisation and activity may be useful as a novel therapeutic tool
against neuronal diseases.
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